x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

214 Resultado(s)

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
STUTTGART

ALEMANHA

Baden-Württemberg
ULM

Ensaio a decorrerCOUP-1: Copanlisib and Rituximab in Marginal Zone Lymphoma Patients
Universitätsklinikum Ulm
Institut für Experimentelle Tumorforschung

ALEMANHA

Bayern
MÜNCHEN

ALEMANHA

Berlin
ADDRESS: NOT PROVIDED - DE

ALEMANHA

Hessen
GIEßEN

B-NHL BFM Rituximab: Multicenter phase II therapy study for children with mature B-NHL or B-ALL with a Rituximab - Window before Chemotherapy - DE
Kinderklinik des UKGM am Standort Gießen
Abteilung für Pädiatrische Hämatologie und Onkologie

ALEMANHA

Nordrhein-Westfalen
KÖLN

Ensaio a decorrerHD18 for advanced stages in Hodgkins Lymphoma (Phase III) - DE
Universitätsklinikum Köln
Klinik I für Innere Medizin

ALEMANHA

Nordrhein-Westfalen
MÜNSTER

B-NHL BFM Rituximab: Multicenter phase II therapy study for children with mature B-NHL or B-ALL with a Rituximab - Window before Chemotherapy - DE
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

AUSTRIA

OBERÖSTERREICH
LINZ

AUSTRIA

SALZBURG
SALZBURG

AUSTRIA

TIROL
INNSBRUCK

AUSTRIA

TIROL
INNSBRUCK

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
WIEN

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
LOUVAIN-LA-NEUVE

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

ESPANHA

Comunidad Valenciana
VALENCIA

ESPANHA

Comunidad Valenciana
VALENCIA

ESPANHA

Madrid
MADRID

ESPANHA

Murcia
EL PALMAR, MURCIA

Ensaio em fase de recrutamentoEnsaio a decorrerMultinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome OMS/DES (phase III) - ES
Hospital Clínico Universitario Virgen de la Arrixaca
Servicio de Oncohematología Pediátrica

FRANCA

ILE-DE-FRANCE
CRÉTEIL

Rituximab (Mabthera) efficacy evaluation in adults suffering from chronic immune and severe thrombocytopenic purpura and potential candidate for splenectomy (Phase II)
Établissement Français du Sang - Ile de France - Site Henri Mondor
Laboratoire d'immunologie leucoplaquettaire et d'histocompatibilité

FRANCA

ILE-DE-FRANCE
PARIS

MAINRISTAN: MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCA

ILE-DE-FRANCE
PARIS

RATTRAP : Infliximab versus rituximab in systemic necrosing vascularizes with positive ANCA after relapse or resistant immunosuppressant therapies (Phase III) - Terminated -
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCA

ILE-DE-FRANCE
PARIS

Feasibility and efficiency of Rituximab associated with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
CHU Paris Est - Hôpital Saint-Antoine
Service d'hématologie clinique et thérapie cellulaire

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoAssociation of Rituximab to Plasma Exchange in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura (Phase II)
CHU Paris Est - Hôpital Saint-Antoine
Service d'hématologie clinique et thérapie cellulaire

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoFORCE : phase II trial of rituximab in myositis linked to anti-JO1 or anti-SRP antibodies or conventional treatment refractory myasthenia
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Laboratoire Immunologie - Immunopathologie - Immunothérapie (I3) - INSERM UMRS 959

FRANCA

ILE-DE-FRANCE
PARIS

Treatment of aggressive lymphoma in adults: NHL 98
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Institut Universitaire d'Hématologie

FRANCA

ILE-DE-FRANCE
PARIS

FRANCA

ILE-DE-FRANCE
PARIS

FRANCA

ILE-DE-FRANCE
SAINT-CLOUD

ITALIA

EMILIA ROMAGNA
BOLOGNA

Ensaio em fase de recrutamentoEnsaio a decorrerStudy of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Dipartimento di Ematologia e Scienze Oncologiche

ITALIA

FRIULI VENEZIA GIULIA
UDINE

ITALIA

LAZIO
ROMA

Ensaio a decorrerEfficacy of monoclonal anti CD 20 antibodies in steroid and cyclosporin dependent nephrotic syndrome in children - IT
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
Laboratorio di Nefrologia - Divisione di Nefrologia e Dialisi

ITALIA

LAZIO
ROMA

Ensaio a decorrerA Phase 2 Multicenter Study to Assess the Activity and the Safety of Front-line Ibrutinib Plus Rituximab (IR) in Unfit Patients With Chronic Lymphocytic Leukemia (CLL)
Sapienza Università di Roma - Dipartimento di Neurologia e Psichiatria
Dipartimento di Biotecnologie Cellulari ed Ematologia

ITALIA

LOMBARDIA
RANICA

ITALIA

PIEMONTE
TORINO

ITALIA

PUGLIA
BARI

Ensaio em fase de recrutamentoEnsaio a decorrerCombined Therapy With Peg-Interferon alpha, Ribavirin And Rituximab Of Hepatitis C Virus-Related Mixed Cryoglobulinemia - IT
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Unità di Epatologia - Sezione di Medicina Interna e Oncologia Clinica

PAISES BAIXOS

Gelderland
NIJMEGEN

PAISES BAIXOS

Groningen
GRONINGEN

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
UMCG - Universitair Medisch Centrum Groningen
Afdeling Reumatologie & Klinische Immunologie

PAISES BAIXOS

Utrecht
UTRECHT

Ensaio a decorrerAnti-CD20 Therapy for the treatment of Chronic Graft Versus Host Disease
UMC Utrecht - Universitair Medisch Centrum Utrecht
Afdeling Hematologie

PAISES BAIXOS

Zuid-Holland
ROTTERDAM

Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
Erasmus MC, Locatie Daniel den Hoed
Erasmus MC Kanker Instituut Daniel den Hoed

REINO UNIDO

Devon
PLYMOUTH

REINO UNIDO

Devon
PLYMOUTH

REINO UNIDO

Tyne & Wear
NEWCASTLE UPON TYNE

Ensaio em fase de recrutamentoEnsaio a decorrerRITPBC: Rituximab for the Treatment of Fatigue in Primary Biliary Cirrhosis (PBC)
Faculty of Medical Sciences
Clinical Academic Office

REINO UNIDO

Tyne & Wear
NEWCASTLE UPON TYNE

Ensaio em fase de recrutamentoEnsaio a decorrerRADS2: Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison's Disease
Institute of Genetic Medicine - International Centre for Life
Endocrine and Renal Genetics

Ensaio (s) clínico (s) multinacional (ais)